The Expression and Prognostic Impact of CD95 Death Receptor and CD20, CD34 and CD44 Differentiation Markers in Pediatric Acute Lymphoblastic Leukemia

Abstract

Description

Keywords

Citation

URI

Endorsement

Review

Supplemented By

Referenced By